trial,pubID,pseudogroup,weeks,group,IgD-/IgM-/IgA-/IgG+/KO-/Antigen++ B cells
G002,G002-831,G002,4,2,7500.0
G002,G002-341,G002,4,2,4014.0
G002,G002-852,G002,4,1,3568.0
G002,G002-136,G002,4,2,3854.0
G002,G002-616,G002,4,1,3608.0
G002,G002-502,G002,4,1,4382.0
G002,G002-293,G002,4,2,2676.0
G002,G002-371,G002,4,3,3075.0
G002,G002-630,G002,4,2,3167.0
G002,G002-997,G002,4,3,2031.0
G002,G002-119,G002,4,2,1394.0
G002,G002-477,G002,4,3,3906.0
G002,G002-145,G002,4,2,2709.0
G002,G002-619,G002,4,1,2169.0
G002,G002-758,G002,4,1,1576.0
G002,G002-931,G002,4,3,2353.0
G002,G002-820,G002,4,2,2687.0
G002,G002-516,G002,4,1,1215.0
G002,G002-855,G002,4,2,1648.0
G002,G002-689,G002,4,3,1403.0
G002,G002-493,G002,4,2,1119.0
G002,G002-577,G002,4,2,3195.0
G002,G002-546,G002,4,1,1506.0
G002,G002-796,G002,4,3,1700.0
G002,G002-230,G002,4,2,3562.0
G002,G002-595,G002,4,3,1152.0
G002,G002-813,G002,4,1,675.0
G002,G002-678,G002,4,1,1452.0
G002,G002-884,G002,4,3,1178.0
G002,G002-254,G002,4,1,1371.0
G002,G002-943,G002,4,2,3408.0
G002,G002-825,G002,4,3,1071.0
G002,G002-957,G002,4,2,1594.0
G002,G002-866,G002,4,3,1237.0
G002,G002-479,G002,4,1,1129.0
G002,G002-278,G002,4,3,978.0
G002,G002-834,G002,4,1,1099.0
G002,G002-302,G002,4,1,968.0
G002,G002-733,G002,4,1,2267.0
G002,G002-969,G002,4,1,438.0
G002,G002-632,G002,4,3,938.0
G002,G002-304,G002,4,3,601.0
G002,G002-810,G002,4,3,765.0
G002,G002-905,G002,4,1,285.0
G002,G002-871,G002,4,3,612.0
G002,G002-988,G002,4,3,1376.0
G002,G002-427,G002,4,3,201.0
G002,G002-947,G002,4,2,177.0
G002,G002-620,G002,4,2,375.0
G002,G002-480,G002,4,2,142.0
G002,G002-462,G002,4,3,273.0
